Stay updated on Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe site revision label was updated from v3.8.0 to v3.8.1, with no change to the study record history.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.0%

- Check31 days agoChange DetectedAn NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the page, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.4%

- Check45 days agoChange DetectedThe site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check66 days agoChange DetectedFooter revision label updated from v3.6.6 to v3.7.0, indicating a newer page template/version was deployed. The change does not alter study data or visible content on the record page.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a small platform update that doesn't modify the study record content.SummaryDifference0.0%

Stay in the know with updates to Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo Vs Pom-Dex in Myeloma Clinical Trial page.